Compare ABEO & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABEO | RFI |
|---|---|---|
| Founded | 1974 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 320.7M |
| IPO Year | 2005 | N/A |
| Metric | ABEO | RFI |
|---|---|---|
| Price | $4.95 | $11.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $18.75 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 89.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | ★ 38.74 | N/A |
| EPS | ★ 1.35 | N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,589.77 | N/A |
| P/E Ratio | $3.53 | ★ N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $3.93 | $10.43 |
| 52 Week High | $7.54 | $12.19 |
| Indicator | ABEO | RFI |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 37.49 |
| Support Level | $4.87 | $11.37 |
| Resistance Level | $5.60 | $11.46 |
| Average True Range (ATR) | 0.20 | 0.13 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 27.73 | 9.21 |
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.